Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke

Author(s): Sabrina Anticoli, Maria Cristina Bravi, Giovanni Perillo, Antonio Siniscalchi, Claudio Pozzessere, Francesca Romana Pezzella, Piero Tanzi, Luca Gallelli, Domenico Cartoni.

Journal Name: Current Neurovascular Research

Volume 13 , Issue 3 , 2016

Submit Manuscript
Submit Proposal

Abstract:

Previous clinical studies suggest that intravenous (IV) recombinant tissue plasminogen activator (rt-PA) benefits stroke patients regardless of the underlying etiology. In this study, we assessed the possible differences in response to IV rt-PA between cardioembolic stroke and other stroke subtypes. A total of 303 consecutive stroke ischemic patients (from January 2005 to April 2014) admitted to our Stroke Unit and treated with IV rt-PA were retrospectively reviewed. All patients were classified in two groups: Cardioembolic (CE) and Non-Cardioembolic (NCE). We analyzed a total of 303 patients. Thirty patients died in the first hours after fibrinolysis and no statistically significant differences were found in two groups (14 CE vs 18 N-CE). We observed a significant differences in clinical outcome in terms of symptoms ”improvement” (p<0.01 2) and symptoms” regression” (p<0.057 2) even if this last result did not reach statistical significance in CE patients respect to N-CE patients.

In conclusion, the intravenous fibrinolysis is more effective in CE group than in N-CE regarding symptoms ”improvement” and the PFO-Stroke patients treated with fibrinolysis have better outcome than other patients and they have high rate of symptoms” regression”. Moreover the main predictor of good outcomes were younger age and milder stroke severity on hospital admission.

Keywords: rt-PA, cardioembolic stroke, non-cardioembolic stroke, PFO-Stroke patients, symptoms improvement, symptoms regression.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 13
ISSUE: 3
Year: 2016
Page: [193 - 198]
Pages: 6
DOI: 10.2174/1567202613666160506125426
Price: $58

Article Metrics

PDF: 27
HTML: 2